Online citations, reference lists, and bibliographies.
← Back to Search

Cosmeceuticals Based On Rhealba® Oat Plantlet Extract For The Treatment Of Acne Vulgaris

G. Fabbrocini, M. Saint Aroman
Published 2014 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Recent evidence suggests that acne vulgaris begins as an inflammation in and around the sebaceous gland and alterations in the lipid content of sebum, which drive hyperproliferation and increased desquamation of keratinocytes within sebaceous follicles. This prevents sebum drainage, causing the formation of microcomedones, which spontaneously regress or become acne lesions when the pilosebaceous unit is further blocked by the accumulation of corneocytes. These conditions are favourable for the proliferation of Propionibacterium acnes, which further aggravates acne by enhancing abnormal desquamation, sebum production and inflammation. Also, skin fragility due to inflammation or irritation by anti‐comedogenic agents can worsen the situation. Rhealba® Oat plantlet extract (Pierre Fabre Dermo Cosmetique) soothes and restores fragile skin in acne by reducing inflammation and inhibits bacterial adhesion of Propionibacterium acnes. Cosmeceuticals combining Rhealba® Oat plantlet extract and hydro‐compensating actives, which are available with or without anti‐comedogenic hydroxy acids, provide a balanced, multifaceted approach for acne patients.
This paper references
10.1186/1471-5945-13-10
Toll-like receptor 2 activation and comedogenesis: implications for the pathogenesis of acne
Joanne L. Selway (2013)
Topical effectiveness of a cosmetic skincare treatment for acne-prone skin: a clinical study.
I. Bartenjev (2011)
10.2147/CCID.S34029
Glycolic acid peel therapy – a current review
J. Sharad (2013)
10.1111/j.1473-2165.2010.00513.x
Research Letter: Lactic acid peeling in superficial acne scarring in Indian skin
S. Sachdeva (2010)
10.1080/10915810305072
Biography of Victor Aleksandrovich Tutelyan
B. A. Kurlyandski (2003)
Topical retinoids in acne vulgaris: update on efficacy and safety
A Thielitz (2008)
10.2165/0128071-200910001-00001
Cleansing and Moisturizing in Acne Patients
G. Goodman (2009)
10.1111/j.1468-3083.2011.04214.x
Female acne – a different subtype of teenager acne?
S. Preneau (2012)
10.1111/j.1365-2133.1980.tb06590.x
Detection of the action of salicylic acid on the normal stratum corneum
D. L. Roberts (1980)
10.1034/j.1600-0625.12.s2.9.x
Biological effects of glycolic acid on dermal matrix metabolism mediated by dermal fibroblasts and epidermal keratinocytes
Yuri Okano (2003)
The effects of topical alpha-hydroxyacids on the normal skin barrier of hairless mice.
T. H. Kim (2001)
10.1007/s004030050212
Mode of action of glycolic acid on human stratum corneum: ultrastructural and functional evaluation of the epidermal barrier
M. Fartasch (1997)
10.1038/jid.2011.23
Filaggrin null mutations are not a protective factor for acne vulgaris.
J. E. Common (2011)
10.1055/s-0030-1250649
Rhealba® oat plantlet extract: evidence of protein-free content and assessment of regulatory activity on immune inflammatory mediators.
A. Mandeau (2011)
Topical acne drugs: review of clinical properties, systemic exposure, and safety
A Akhavan (2003)
10.1111/j.1365-2133.2011.10375.x
A microbial aetiology of acne: what is the evidence?
B. Shaheen (2011)
10.1111/ced.12252
Acne, quorum sensing and danger
S. M. Lwin (2014)
Acne Vulgaris and the Epidermal Barrier: Is Acne Vulgaris Associated with Inherent Epidermal Abnormalities that Cause Impairment of Barrier Functions? Do Any Topical Acne Therapies Alter the Structural and/or Functional Integrity of the Epidermal Barrier?
D. Thiboutot (2013)
10.1111/j.0906-6705.2005.00224.x
Effects of glycolic acid on desquamation‐regulating proteinases in human stratum corneum
T. Horikoshi (2005)
Clinical relevance of skin barrier changes associated with the use of oral isotretinoin: the importance of barrier repair therapy in patient management.
J. D. Del Rosso (2013)
Colloidal oatmeal: history, chemistry and clinical properties.
E. Kurtz (2007)
10.1111/1523-1747.EP12398620
Stratum corneum moisturization at the molecular level.
A. V. Rawlings (1994)
10.1016/S0149-2918(98)80134-3
Efficacy and safety of azelaic acid and glycolic acid combination therapy compared with tretinoin therapy for acne.
M. Spellman (1998)
10.1111/j.1473-2165.2011.00572.x
A 10% glycolic acid containing oil-in-water emulsion improves mild acne: a randomized double-blind placebo-controlled trial.
C. Abels (2011)
10.1016/j.clindermatol.2009.06.023
Clinical and cosmeceutical uses of hydroxyacids.
B. Green (2009)
10.4103/0019-5154.103063
Lactic Acid as a New Therapeutic Peeling Agent in the Treatment of Lifa Disease (Frictional Dermal Melanosis)
K. Sharquie (2012)
10.1111/j.1346-8138.2011.01405.x
Efficacy of the addition of salicylic acid to clindamycin and benzoyl peroxide combination for acne vulgaris
S. Akarsu (2012)
10.1111/j.1467-2494.2004.00225.x
In vivo assessment of the efficacy of an innovative face care system in subjects with mild acne vulgaris 1
U. Scherdin (2004)
10.2340/0001555575455458
Functional changes in human stratum corneum induced by topical glycolic acid: comparison with all-trans retinoic acid.
I. Effendy (1995)
10.1046/j.1365-2133.1999.03038.x
Role of endogenous cathepsin D‐like and chymotrypsin‐like proteolysis in human epidermal desquamation
Horikoshi (1999)
[Acne vulgaris].
M. Toscano (1992)
Beneficial effect of a moisturizing cream as adjunctive treatment to oral isotretinoin or topical tretinoin in the management of acne.
S. Laquièze (2006)
The role of inflammation in the pathology of acne.
E. Tanghetti (2013)
10.1111/bjd.12149
Epidemiology of acne vulgaris
K. Bhate (2013)
ACNE VULGARIS. EVALUATION OF A MEDICATED CLEANSING PAD.
H. L. Roth (1964)
Moisturizers for the treatment of inflammatory skin conditions.
C. Lynde (2008)
10.1007/s00403-007-0774-5
Modulation of integrins and filaggrin expression by Propionibacterium acnes extracts on keratinocytes
V. Jarrousse (2007)
10.1007/BF00741846
“Keratolytic” effect of salicylic acid
C. Huber (2004)
10.1097/00006534-199002000-00091
Alpha hydroxy acids: procedures for use in clinical practice.
E. V. Van Scott (1989)
10.1111/jdv.12509
Fragility of epidermis and its consequence in dermatology
J. Stalder (2014)
10.1046/J.1523-1747.1998.00143.X
The effects of inflammatory cytokines on the isolated human sebaceous infundibulum.
R. Guy (1998)
10.1007/BF01262335
Impaired water barrier function in acne vulgaris
A. Yamamoto (2005)
10.1111/j.1365-2133.1976.tb00825.x
Studies on the effect of salicylic acid on normal skin
M. Davies (1976)
10.1007/s00403-012-1265-x
The role of androgen and androgen receptor in skin-related disorders
Jiann-jyh Lai (2012)
10.1038/jid.2008.324
Heterozygous null alleles in filaggrin contribute to clinical dry skin in young adults and the elderly.
A. Sergeant (2009)
10.1177/1091581803022S303
Safety assessment of Salicylic Acid, Butyloctyl Salicylate, Calcium Salicylate, C12-15 Alkyl Salicylate, Capryloyl Salicylic Acid, Hexyldodecyl Salicylate, Isocetyl Salicylate, Isodecyl Salicylate, Magnesium Salicylate, MEA-Salicylate, Ethylhexyl Salicylate, Potassium Salicylate, Methyl Salicylate,
(2003)
10.1111/ics.12049
Filaggrin – revisited
C. Harding (2013)
10.1111/srt.12022
Clinical evidence on the efficacy and safety of an antioxidant optimized 1.5% salicylic acid (SA) cream in the treatment of facial acne: an open, baseline‐controlled clinical study
Y. Zheng (2013)
10.1111/1523-1747.EP12477026
Monoclonal antibody labeling for cytokeratins and filaggrin in the human pilosebaceous unit of normal, seborrhoeic and acne skin.
I. Kurokawa (1988)
10.1046/j.1365-2133.2001.04011.x
The effects of topical α‐hydroxyacids on the normal skin barrier of hairless mice
T. H. Kim (2001)
10.1517/14656560903277228
Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris
Matt Sagransky (2009)
10.1067/MJD.2003.618
Management of acne: a report from a Global Alliance to Improve Outcomes in Acne.
H. Gollnick (2003)
10.1016/S0190-9622(84)80466-1
Hyperkeratinization, corneocyte cohesion, and alpha hydroxy acids.
E. V. Van Scott (1984)
10.1016/j.sder.2011.07.002
The acne continuum: an age-based approach to therapy.
S. Friedlander (2011)
10.1159/000093984
‘Keratolytic’ Properties of Benzoyl Peroxide and Retinoic Acid Resemble Salicylic Acid in Man
J. Waller (2006)
10.1016/J.IJPHARM.2004.11.032
Cutaneous bioassay of salicylic acid as a keratolytic.
S. Bashir (2005)
10.1517/14740338.2013.740456
Side effects of common acne treatments
S. Tripathi (2013)
Clinical relevance of skin barrier changes associated with the use of oral isotretinoin: the importance of barrier repair therapy in patient management.
D. Rosso (2013)



This paper is referenced by
10.12968/JOAN.2018.7.SUP2.8
Value of volume restoration procedures with dermal filler in the mid-face
Sarah Boxley (2018)
Intégration des modèles in vitro dans la stratégie d'évaluation de la sensibilisation cutanée
E. Clouet (2018)
10.1111/jdv.13636
Fragility of epidermis in newborns, children and adolescents
U. Blume-Peytavi (2016)
10.1111/jdv.14410
Fragility of epidermis: acne and post‐procedure lesional skin
G. Fabbrocini (2017)
10.1111/jdv.14047
Response to ‘The concept of fragile skin: a case of disease mongering in dermatology?’
U. Blume-Peytavi (2017)
10.1111/jdv.14077
Efficacy of a Rhealba® Oat Extract‐based emollient on chronic pruritus in elderly French outpatients
J. Theunis (2017)
10.1111/jdv.15253
Gerontodermatology: the fragility of the epidermis in older adults
N. Katoh (2018)
10.2147/CCID.S128722
Epidemiology of fragile skin: Internet-based surveys in Mexico and Russia
J. Ocampo-Candiani (2017)
10.1111/jdv.15335
Dermatology today and tomorrow: from symptom control to targeted therapy
U. Blume-Peytavi (2019)
10.1007/978-981-15-0169-2_9
Extracts and Bioactives from Microalgae (Sensu Stricto): Opportunities and Challenges for a New Generation of Cosmetics
L. Zanella (2020)
10.1007/s40257-016-0249-6
The Use of Cosmeceuticals in Acne: Help or Hoax?
B. Barros (2017)
10.1111/jdv.15829
Efficacy of a repair cream based on Rhealba Oat plantlets extract and active healing compounds in peelings: benefit to patient's downtime and pain
J. Ocampo-Candiani (2019)
10.1111/jdv.14846
Effects of a protein‐free oat plantlet extract on microinflammation and skin barrier function in atopic dermatitis patients
A. Wollenberg (2018)
Semantic Scholar Logo Some data provided by SemanticScholar